International Journal of Hematology and Oncology 2022, Vol 32, Num 3 (Special Issue) Page(s): 001-003
The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

Ibrahim C. HAZNEDAROGLU1, Mustafa CETINER2, Osman ILHAN3

1Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, TURKEY
2American Hospital Department of Hematology, Istanbul, TURKEY
3Ankara University Faculty of Medicine, Department of Hematology, Ankara, TURKEY